Articoli con mandati relativi all'accesso pubblico - Ignacio BlancoUlteriori informazioni
Non disponibili pubblicamente: 11
Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: comparison with NICE and SIGN referral criteria
J Cubiella, M Salve, M Díaz‐Ondina, P Vega, MT Alves, F Iglesias, ...
Colorectal Disease 16 (8), O273-O282, 2014
Mandati: Government of Spain
Analysis of intratumor heterogeneity in Neurofibromatosis type 1 plexiform neurofibromas and neurofibromas with atypical features: Correlating histological and genomic findings
M Carrió, B Gel, E Terribas, AC Zucchiatti, T Moliné, I Rosas, Á Teulé, ...
Human mutation 39 (8), 1112-1125, 2018
Mandati: Government of Spain
Comprehensive functional assessment of MLH1 variants of unknown significance
E Borràs, M Pineda, A Brieger, I Hinrichsen, C Gómez, M Navarro, ...
Human mutation 33 (11), 1576-1588, 2012
Mandati: Government of Spain
Assessing the RNA effect of 26 DNA variants in the BRCA1 and BRCA2 genes
M Menéndez, J Castellsagué, M Mirete, E Pros, L Feliubadaló, A Osorio, ...
Breast cancer research and treatment 132, 979-992, 2012
Mandati: Government of Spain
Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers
J Zugazagoitia, P Pérez-Segura, A Manzano, I Blanco, A Vega, ...
Breast cancer research and treatment 148, 415-421, 2014
Mandati: Government of Spain
Exome sequencing identifies MUTYH mutations in a family with colorectal cancer and an atypical phenotype
N Seguí, M Navarro, M Pineda, N Köger, F Bellido, S González, ...
Gut 64 (2), 355-356, 2015
Mandati: Government of Spain
Evidence for a link between TNFRSF11A and risk of breast cancer
N Bonifaci, M Palafox, P Pellegrini, A Osorio, J Benitez, P Peterlongo, ...
Breast cancer research and treatment 129, 947-954, 2011
Mandati: Government of Spain
Identification of a founder EPCAM deletion in Spanish Lynch syndrome families
P Mur, M Pineda, A Romero, J Del Valle, E Borras, A Canal, M Navarro, ...
Clinical Genetics 85 (3), 260-266, 2014
Mandati: Government of Spain
Chromosomal translocations inactivating CDKN2A support a single path for malignant peripheral nerve sheath tumor initiation
M Magallón-Lorenz, J Fernández-Rodríguez, E Terribas, ...
Human Genetics 140 (8), 1241-1252, 2021
Mandati: US National Institutes of Health, Government of Spain
Revisiting the UK Genetic Severity Score for NF2: a proposal for the addition of a functional genetic component
N Catasús, B Garcia, I Galván-Femenía, A Plana, A Negro, I Rosas, A Ros, ...
Journal of Medical Genetics 59 (7), 678-686, 2022
Mandati: Government of Spain
Identification of a new complex rearrangement affecting exon 20 of BRCA1
J Del Valle, O Campos, A Velasco, E Darder, M Menéndez, L Feliubadaló, ...
Breast cancer research and treatment 130, 341-344, 2011
Mandati: Government of Spain
Disponibili pubblicamente: 136
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts
HFA Vasen, I Blanco, K Aktan-Collan, JP Gopie, A Alonso, S Aretz, ...
Gut 62 (6), 812-823, 2013
Mandati: Cancer Research UK
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ...
Cancer Epidemiology, Biomarkers & Prevention 21 (1), 134-147, 2012
Mandati: US National Institutes of Health, Canadian Institutes of Health Research …
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer
KL Bolton, G Chenevix-Trench, C Goh, S Sadetzki, SJ Ramus, BY Karlan, ...
Jama 307 (4), 382-389, 2012
Mandati: US National Institutes of Health, Cancer Research UK, Government of Spain
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
Mandati: US National Institutes of Health, Canadian Institutes of Health Research …
Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
P Møller, TT Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ...
Gut 67 (7), 1306-1316, 2018
Mandati: National Health and Medical Research Council, Australia, Swedish Research …
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ...
Jama 313 (13), 1347-1361, 2015
Mandati: US National Institutes of Health, Cancer Research UK, National Institute for …
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
P Møller, T Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ...
Gut 66 (3), 464-472, 2017
Mandati: Cancer Research UK, UK Medical Research Council, National Institute for …
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
M Dominguez-Valentin, JR Sampson, TT Seppälä, SW Ten Broeke, ...
Genetics in Medicine 22 (1), 15-25, 2020
Mandati: US National Institutes of Health, National Institute for Health Research, UK …
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ...
Science immunology 6 (62), eabl4340, 2021
Mandati: US National Institutes of Health, Howard Hughes Medical Institute, National …
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software